WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • October 29th, 2019 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations
This Warrant Exercise Agreement (this “Agreement”), dated as of October 28, 2019, is by and between Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of a Common Stock Purchase Warrant to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), issued by the Company, which warrant is exercisable at an exercise price (the “Exercise Price”) per share as set forth on the Holder’s signature page hereto (the “Original Warrant”).
